Search

everythinglearnresearchcommunity

for

Search:↓

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

ODC overexpression in hair cells increases tumor growth by reducing Notch signaling.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

CD34 is crucial for skin tumor development in mice.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

TPA is about 50 times more effective at promoting tumors than MZ.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Meis1 is crucial for skin health and tumor development.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

Vitamin D receptor may help protect against UV-induced skin cancer.

Inhibiting ODC can prevent UV-induced skin cancer.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Targeting ornithine decarboxylase can help prevent skin cancer.

UV exposure reduces Lgr6+ stem cells in mouse skin and they don't significantly contribute to skin cancer development.

Collagen XVIII and Bmx tyrosine kinase are important for hair growth and skin cancer development.

Lack of vitamin D receptor increases skin tumor risk by boosting hedgehog signaling.

AP-1 controls tumor cell type by affecting key signaling pathways.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

The transgene likely activated an oncogene or interrupted a tumor suppressor gene, causing melanoma in mice.

The vitamin D receptor can act without its usual activating molecule, affecting hair growth and skin cancer, but its full range of actions is not well understood.